RNA molecules and vectors for gene silencing
First Claim
Patent Images
1. A composition for introduction into a cell to effect gene silencing, consisting essentially of isolated short antisense RNA molecules (SARMs) and isolated short sense RNA molecules (SSRMs), collectively short RNA molecules (SRMs),wherein the SSRMs and SARMs are each of a uniform length of 20-24 nucleotides;
- wherein said SARMs are complementary to and can base pair with a target RNA, which target RNA is transcribed from a gene that is silenced when said SRMs are present in a cell containing said gene, and said SSRMs correspond to the target RNA;
wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan, orsaid target RNA is generated by a pathogen; and
wherein if said SARMs and SSRMs consist of 20 nucleotides, said SARMs and SSRMs are unmodified.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to short RNA molecules of about 25 nucleotides in length, which comprise antisense RNA complementary to a targeted mRNA and corresponding sense RNA molecules. These short RNA molecules are effective in post-transcriptional gene silencing (PTGS).
73 Citations
24 Claims
-
1. A composition for introduction into a cell to effect gene silencing, consisting essentially of isolated short antisense RNA molecules (SARMs) and isolated short sense RNA molecules (SSRMs), collectively short RNA molecules (SRMs),
wherein the SSRMs and SARMs are each of a uniform length of 20-24 nucleotides; -
wherein said SARMs are complementary to and can base pair with a target RNA, which target RNA is transcribed from a gene that is silenced when said SRMs are present in a cell containing said gene, and said SSRMs correspond to the target RNA; wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan, or said target RNA is generated by a pathogen; and wherein if said SARMs and SSRMs consist of 20 nucleotides, said SARMs and SSRMs are unmodified. - View Dependent Claims (2, 4, 5, 6, 7)
-
-
3. An improved composition for introduction into a cell to effect gene silencing, which improved composition comprises isolated short antisense RNA molecules (SARMs) of a uniform length of 20-24 nucleotides;
-
wherein said SARMs are complementary to and can base pair with a target RNA, and; the improvement comprising including in said composition isolated short sense RNA molecules (SSRMs) of a uniform length of 20-24 nucleotides, wherein said SSRMs correspond to said target RNA; wherein said target RNA is transcribed from a gene that is silenced when said SSRMs and SARMs are present in a cell containing said gene, wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan;
or said target RNA is generated by a pathogen;wherein if said SARMs and SSRMs consist of 20 nucleotides, said SARMs and SSRMs are unmodified. - View Dependent Claims (8, 9, 10, 11, 12)
-
-
13. A composition for introduction into a cell to effect gene silencing, which composition comprises at least one vector which, when introduced into a cell, produces short antisense RNA molecules (SARMs) and short sense RNA molecules (SSRMs), said SARMs and SSRMs designated, collectively, short RNA molecules (SRMs),
wherein the SSRMs and SARMs are each of a uniform length of 20-24 nucleotides; -
wherein said SARMs are complementary to and can base pair with a target RNA, which target RNA is transcribed from a gene that is silenced when said SRMs are present in a cell containing said gene, and said SSRMs correspond to the target RNA; wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan, or said target RNA is generated by a pathogen. - View Dependent Claims (14, 15, 16, 17, 18)
-
-
19. An improved composition for introduction into a cell to effect gene silencing, which composition comprises at least one vector which, when introduced into a cell, produces short antisense RNA molecules (SARMs) of a uniform length of 20-24 nucleotides;
-
wherein said SARMs are complementary to and can base pair with a target RNA; the improvement comprising including in said at least one vector sequences such that short sense RNA molecules (SSRMs) are also produced, wherein said SSRMs are of a uniform length of 20-24 nucleotides and said SSRMs correspond to the target RNA; which target RNA is transcribed from a gene that is silenced when said SARMs and SSRMs are present in a cell containing said gene, wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan, or said target RNA is generated by a pathogen. - View Dependent Claims (20, 21, 22, 23, 24)
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneePlant Bioscience Limited (Alnylam Pharmaceuticals Incorporated)
-
Original AssigneePlant Bioscience Limited (Alnylam Pharmaceuticals Incorporated)
-
InventorsBaulcombe, David Charles, Hamilton, Andrew John
-
Primary Examiner(s)Fox, David T
-
Application NumberUS11/013,316Publication NumberTime in Patent Office2,818 DaysField of Search514/44, 536/23.1, 536/23.2, 536/24.5, 536/24.3, 536/24.31, 536/24.33US Class Current536/24.5CPC Class CodesA01N 57/16 containing heterocyclic rad...A61P 43/00 Drugs for specific purposes...C12N 15/113 Non-coding nucleic acids mo...C12N 15/8218 Antisense, co-suppression, ...
